Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US8816242098

SecurityTEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
InstitutionAperio Group, LLC
Latest Disclosed Ownership122,805 shares
Latest Disclosed Value $ 1,185,000
Aperio Group, LLC reports 52.28% decrease in ownership of TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)

On February 5, 2021 - Aperio Group, LLC filed a 13F-HR form disclosing ownership of 122,805 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) (US:TEVA) valued at $1,185,068 USD as of December 31, 2020. The entity filed a previous 13F-HR on November 6, 2020 disclosing 257,327 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock). This represents a change in shares of -52.28% during the quarter. The current value of the position is $4,198,703 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2021-02-05 2020-12-31 13F TEVA PHARMACEUTICAL INDUSTRIES SPONSORED ADS 881624209 122,805 -134,522 -52.28 1,185 -48.90 0.0035
2020-11-06 2020-09-30 13F TEVA PHARMACEUTICAL INDUSTRIES SPONSORED ADS 881624209 257,327 -10,269 -3.84 2,319 -29.71 0.0078
2020-08-13 2020-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 267,596 415 0.16 3,299 37.52 0.0122
2020-05-05 2020-03-31 13F TEVA PHARMACEUTICAL INDUSTRIES SPONSORED ADS 881624209 267,181 15,678 6.23 2,399 -2.68 0.0106
2020-02-13 2019-12-31 13F TEVA PHARMACEUTICAL INDUSTRIES SPONSORED ADS 881624209 251,503 78,405 45.30 2,465 106.97 0.0089
2019-11-06 2019-09-30 13F TEVA PHARMACEUTICAL INDUSTRIES SPONSORED ADS 881624209 173,098 49,641 40.21 1,191 4.47 0.0047
2019-07-30 2019-06-30 13F TEVA PHARMACEUTICAL INDUSTRIES SPONSORED ADS 881624209 123,457 -88,210 -41.67 1,140 -65.65 0.0047
2019-05-13 2019-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 211,667 -47,815 -18.43 3,319 -17.05 0.0143
2019-05-06 2018-12-31 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 259,482 -105,095 -28.83 4,001 -49.05 0.0202
2019-02-14 2018-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 259,833 -104,744 4,007
2019-05-06 2018-09-30 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 364,577 -1,643 -0.45 7,853 -11.82 0.0347
2018-10-17 2018-09-30 13F TEVA PHARMACEUTICAL I COMMON 881624209 364,577 -1,643 7,853
2019-05-06 2018-06-30 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 366,220 74,131 25.38 8,906 78.41 0.0426
2018-07-30 2018-06-30 13F TEVA PHARMACEUTICAL I COMMON 881624209 366,220 74,131 8,906
2019-05-01 2018-03-31 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 292,089 30,860 11.81 4,992 0.85 0.0248
2018-05-08 2018-03-31 13F TEVA PHARMACEUTICAL I COMMON 881624209 292,089 30,860 4,992
2019-05-01 2017-12-31 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 261,229 88,374 51.13 4,950 62.72 0.0256
2018-02-02 2017-12-31 13F TEVA PHARMACEUTICAL I COMMON 881624209 261,229 88,374 4,950
2019-05-01 2017-09-30 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 172,855 -20,061 -10.40 3,042 -52.54 0.0172
2017-10-25 2017-09-30 13F TEVA PHARMACEUTICAL I COMMON 881624209 172,855 -20,061 3,042
2019-04-22 2017-06-30 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 192,916 17,634 10.06 6,409 13.94 0.0393
2017-07-18 2017-06-30 13F TEVA PHARMACEUTICAL I COMMON 881624209 192,916 17,634 6,409
2019-04-22 2017-03-31 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 175,282 -17,273 -8.97 5,625 -19.41 0.0385
2017-05-05 2017-03-31 13F TEVA PHARMACEUTICAL I COMMON 881624209 175,282 -17,273 5,625
2019-04-22 2016-12-31 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 192,555 -316,142 -62.15 6,980 -70.18 0.0534
2017-02-14 2016-12-31 13F TEVA PHARMACEUTICAL I COMMON 881624209 192,555 -316,142 6,980
2019-04-12 2016-09-30 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 508,697 54,213 11.93 23,405 2.52 0.1694
2016-11-01 2016-09-30 13F TEVA PHARMACEUTICAL I COMMON 881624209 508,697 54,213 23,405
2019-04-12 2016-06-30 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 454,484 17,510 4.01 22,829 -2.37 0.1785
2016-08-12 2016-06-30 13F TEVA PHARMACEUTICAL I COMMON 881624209 454,484 17,510 22,829
2019-04-12 2016-03-31 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 436,974 -3,071 -0.70 23,382 -19.05 0.2000
2016-04-28 2016-03-31 13F TEVA PHARMACEUTICAL I COMMON 881624209 436,974 -3,071 23,382
2016-01-21 2015-12-31 13F TEVA PHARMACEUTICAL I COMMON 881624209 440,045 56,542 14.74 28,885 33.40 0.2646
2015-10-19 2015-09-30 13F TEVA PHARMACEUTICAL I COMMON 881624209 383,503 37,414 10.81 21,653 5.86 0.2203
2015-07-29 2015-06-30 13F TEVA PHARMACEUTICAL I COMMON 881624209 346,089 51,966 17.67 20,454 11.62 0.2111
2015-04-29 2015-03-31 13F TEVA PHARMACEUTICAL I COMMON 881624209 294,123 294,123 0.00 18,324 0.2052
2015-01-30 2014-12-31 13F TEVA PHARMACEUTICAL I COMMON 881624209 0 -204,298 -100.00 0 -100.00
2014-10-21 2014-09-30 13F TEVA PHARMACEUTICAL I COMMON 881624209 204,298 14,350 7.55 10,981 10.28 0.1484
2014-07-23 2014-06-30 13F TEVA PHARMACEUTICAL I COMMON 881624209 189,948 11,933 6.70 9,957 5.86 0.1446
2014-04-25 2014-03-31 13F TEVA PHARMACEUTICAL I COMMON 881624209 178,015 9,406 51.81 0.1322
2014-01-30 2013-12-31 13F TEVA PHARMACEUTICAL I COMMON 881624209 6,196 19.02 0.0961
2013-10-24 2013-09-30 13F TEVA PHARMACEUTICAL I COMMON 881624209 137,804 16,504 13.61 5,206 9.48 0.1004
2013-07-19 2013-06-30 13F TEVA PHARMACEUTICAL I COMMON 881624209 121,300 4,755
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.